A nimble inside-the-Beltway operative, Stephen Ubl took the reins of the Pharmaceutical Research and Manufacturers of America just as public outrage over high drug prices was hitting its peak. In an interview with Modern Healthcare Editor Merrill Goozner, Ubl shares his views on the drug-price debate. See an edited version of their discussion here.
'Drug prices are the wrong target,' says PhRMA chief
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You